Wall Street Analysts See a 60.61% Upside in Amicus Therapeutics (FOLD): Can the Stock Really Move This High?

Amicus Therapeutics (FOLD) closed the last trading session at $9.9, gaining 5.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 15.9 indicates a 60.6% upside potential.The average comprises 10 short-term price targets ranging from a low of $11.00 to a high of$ 21.00, with a standard deviation of $3.35. While the lowest estimate indicates an increase of 11.1% from the current pric ...